Na+/K+-ATPase α1 subunit, a novel therapeutic target for hepatocellular carcinoma
Liping Zhuang1, Litao Xu1, Peng Wang1
1Department of Integrative Medicine, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Collaborative Innovation Center for Cancer Medcine, Shanghai, China.
Abstract:
We aimed to identify the expression patterns of Na+/K+-ATPase (NKA) α subunits in human hepatocellular carcinoma (HCC) samples and evaluate these subunits as potential targets for HCC treatment. The mRNA expression profiles of NKA α subunits in human HCC samples were analyzed. We found that the mRNA expression for NKA α1 subunit (ATP1A1) was higher than that for other NKA α subunits. Also, ATP1A1 gene expression was markedly higher in HCC samples than in adjacent nontumor tissue samples. Western blotting data suggested that 6 of 14 (43%) HCC samples had elevated ATP1A1 protein expression. Furthermore, knockdown of ATP1A1 expression in human HCC HepG2 and MHCC97H cells markedly reduced their proliferation in vitro and suppressed the tumorigenicity of MHCC97H cells in vivo. Downregulation of ATP1A1 expression resulted in cell-cycle arrest at G2/M phase and apoptosis in HepG2 cells as well as decreased migration in Hep3B cells. We further validated that ATP1A1 downregulation caused intracellular accumulation of reactive oxygen species. Pretreatment with N-acetyl cysteine blocked cell-growth inhibition induced by ATP1A1 downregulation. Collectively, these data suggested that targeting ATP1A1 is a novel approach to the treatment of HCC.
Insights
Targeting the Na+/K+-ATPase alpha 1 subunit (ATP1A1) shows promise for hepatocellular carcinoma (HCC) treatment. Inhibiting ATP1A1 reduces HCC cell proliferation, migration, and tumorigenicity, offering a novel therapeutic strategy.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Hepatocellular carcinoma (HCC) remains a significant global health challenge with limited effective treatments.
- Understanding the molecular mechanisms driving HCC progression is crucial for developing novel therapeutic strategies.
Purpose of the Study:
- To investigate the expression patterns of Na+/K+-ATPase (NKA) alpha subunits in human HCC.
- To evaluate the potential of NKA alpha subunits, particularly ATP1A1, as therapeutic targets for HCC.
Main Methods:
- Analysis of mRNA expression profiles of NKA alpha subunits in human HCC and adjacent non-tumor tissues.
- Western blotting to assess ATP1A1 protein levels in HCC samples.
- In vitro and in vivo experiments involving ATP1A1 knockdown in HCC cell lines (HepG2, MHCC97H, Hep3B).
- Assessment of cell proliferation, cell-cycle arrest, apoptosis, migration, and reactive oxygen species (ROS) levels.
Main Results:
- The mRNA and protein expression of the NKA alpha 1 subunit (ATP1A1) were significantly elevated in HCC tissues compared to non-tumor tissues.
- Knockdown of ATP1A1 suppressed HCC cell proliferation in vitro and tumorigenicity in vivo.
- ATP1A1 downregulation induced G2/M cell-cycle arrest, apoptosis, and decreased migration in HCC cells.
- Reduced ATP1A1 expression led to intracellular ROS accumulation, which was mitigated by N-acetyl cysteine.
Conclusions:
- ATP1A1 is overexpressed in HCC and plays a critical role in tumor growth and progression.
- Targeting ATP1A1 represents a novel and promising therapeutic strategy for hepatocellular carcinoma.
- Further investigation into ATP1A1-targeted therapies could lead to improved clinical outcomes for HCC patients.
More Related Videos
Related Concept Videos
ATP Synthase: Mechanism
ATP Driven Pumps III: V-type Pumps
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Active Transport
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...


